Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Major Shareholding Notification 2018

Feb 26, 2018

65058_rns_2018-02-26_79a8348f-3163-4475-8677-a2f91f825664.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

ŀ.

Form 605

Corporations Law Section 671B

Notice of ceasing to be a substantial holder

Io Company Name/Scheme Primary Health Care
ACN/ARSN 064 530 519

1. Details of substantial holder(1)

Name Maple-Brown Abbott Limited
ACN (if applicable) 001 208 564
The holder ceased to be a
substantial holder on
27/02/2018
The previous notice was given to the company on 27/02/2018
The previous notice was dated 23/02/2018

2. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the
substantial holder was last required

Date of
change
Person whose
relevant interest
changed
Nature of
change (4)
Consideration
given in relation
to change(5)
Class (6) and
number of
securities
affected
Person's votes
affected
27/02/18 See Annexure A Sales -See Annexure в

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN (if applicable) Nature of association
N/A N/A

4. Addresses

The addresses of persons named in this form are as follows:

Name Address
Maple-Brown Abbott Limited [Level 31, 259 George Street, Sydney
NSW
2000

Signature

print name Dean Smedley capacity Company Secretary
sign here Incolley date 27/ 02 / 2018

$\overline{a}$

$\cdot$

DIRECTIONS

  • If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an
    equity trust), the names could be included in an ann $(1)$ throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.
  • See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001. $(2)$
  • $(3)$ See the definition of "associate" in section 9 of the Corporations Act 2001.
  • Include details of: $(4)$
  • any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any $(a)$ document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
  • any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to $(b)$ which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • $(5)$ Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
  • The voting shares of a company constitute one class unless divided into separate classes. $(6)$
  • Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice. $\left( 7\right)$
Registered Shareholdings as at 23 February 2018
Primary Health Care
Registered Name Address
National Nominees Limited GPO Box 1406M, MELBOURNE VIC 3001
J.P. Morgan Nominees Australia Limited Level 18, JP Morgan House, 85 Castlereagh Street, SYDNEY NSW 2000
State Street Australia Ltd Unlisted Unit Trust Department, State Street Australia Limited, 420 George Street, SYDNEY NSW
RBC Investor Services Australia Nominees Pty Limited Level 47, 2 Park Street, SYDNEY NSW 2000
The Northern Trust Company 46th Floor, UOB Plazza 1, 80 Raffles Place, SINGAPORE SINGAPORE 048624
Brown Brothers Harriman Infomediary 40 Water Street, BOSTON MASSACHUSETTS 02109
Citicorp Nominees Pty Ltd Level 2, 350 Collins Street, MELBOURNE VIC 3001
Brown Brothers Harriman 40 Water Street, BOSTON MA 02109
HSBC Custody Nominees (Australia) Limited HSBC Custody and Clearing, Level 13, 580 George Street, SYDNEY NSW 2000
MF Custodians Level 32, 360 Collins Street, MELBOURNE VIC 3000
Garth Rossler c/- Maple-Brown Abbott Limited, Level 31, 259 George Street, SYDNEY NSW 2000

$27/2/298$

c/- Maple-Brown Abbott Limited, Level 31, 259 George Street, SYDNEY NSW 2000

Fonthill Pty Ltd

Annexure A

5,562,293
3,895,747

2,580,494

889,281 593,881 495,500 438,807 403,200 345,700

4,500 82,000

26,656,258

$\ddot{\phantom{0}}$

Holding
11,364,855

Annexure B

Primary Health Care

Net Trades between 26 February 2018 and 27 February 2018

Date

26-Feb-2018 27-Feb-2018

Quantity $(301,000)$ $(335, 500)$ $(636, 500)$

Consideration $(1, 171, 572.24)$ $(1,316,896.55)$ $(2,488,468.79)$

medly 22/2/2018